| Clinicopathological parameters | MYD88 L265P gene mutation | P value | |
| Wild type (N = 32) | Mutant type (N = 8) | ||
| Ann Arbor staging |
|
| 0.042 |
| I-II | 12 | 1 |
|
| III-IV | 20 | 7 | |
| B symptoms |
|
| 1.000 |
| yes | 11 | 3 |
|
| no | 21 | 5 | |
| ECOG PS score |
|
| 0.202 |
| <2 | 23 | 5 |
|
| ≥2 | 9 | 3 | |
| IPI score |
|
| 0.039 |
| Low risk | 5 | 0 |
|
| Medium-low risk | 13 | 0 | |
| Medium-high risk | 11 | 4 | |
| Extremely high risk | 3 | 4 | |
| NCCN-IPI score |
|
| 0.041 |
| Low risk | 6 | 0 |
|
| Medium-low | 13 | 2 | |
| Medium-high | 10 | 4 | |
| Extremely high risk | 3 | 2 | |